Reclaiming UC Symptom Relief May Be Possible

XELJANZ has helped some people with moderate to severe UC achieve remission at 8 weeks and stay in remission at 1 year.

XELJANZ is used to treat adults with moderately to severely active ulcerative colitis when 1 or more TNF blocker medicines have been used, and did not work well or cannot be tolerated.

Results From UC Clinical Trials* Prove XELJANZ Can Help Provide:

DISEASE

REMISSION

at 8 weeks

XELJANZ can help some patients achieve remission at 8 weeks.

STEROID-FREE

REMISSION

at 1 year

XELJANZ can help provide lasting, steroid-free remission in some patients at 1 year.

SYMPTOM

REDUCTION

in 2 weeks

XELJANZ can help reduce symptoms of rectal bleeding and stool frequency in some patients in as early as 2 weeks.


Adult patients with moderately to severely active UC were evaluated in clinical trials. Some patients in the clinical studies were taking background medicines and some were not. All patients in the studies had tried other medicines such as corticosteroids, azathioprine, or TNF blockers that did not work well or could not be tolerated. XELJANZ is approved for use in patients when TNF blockers did not work well or could not be tolerated.

Explore Clinical Trial Results

Discussing UC

If your current treatment isn’t working well enough to manage your UC symptoms, it’s important to have an open and honest discussion with your doctor. Every appointment is an opportunity to improve the dialogue with your doctor and discuss how to manage your UC. If XELJANZ is appropriate for you and you want to continue with Pfizer's savings and support, make sure to ask your doctor to stay on brand-name XELJANZ.

Prepare

Write down any questions or concerns you have ahead of your appointment. This can help make the conversation easier and give your doctor a more complete picture of your symptoms.

Share

When you’re with your GI or another member of your healthcare team, you may feel uncomfortable talking, but it’s important that you share. The information you share with your doctor could be helpful in finding a treatment plan that may work best for you.

Align

Communicate with your healthcare team to help them understand your goals, concerns, and expectations. This conversation will be useful in getting everyone on the same page.

View Doctor Discussion Guide

Savings & Support

Are you starting on treatment with XELJANZ for UC, but you’re concerned about covering the cost? You may be eligible for the XELJANZ Co-Pay Savings Program for commercially insured patients or qualify for other financial support resources to help you access your treatment. Terms and conditions and eligibility requirements apply.

Pay as little as $0 per month for your XELJANZ prescription

Eligibility required. May have annual savings up to $4,000-$15,000 depending on insurance.
Federal and state healthcare beneficiaries ineligible. No membership fee. Offer not valid
for cash paying patients. Terms and conditions apply.

XELJANZ Co-Pay XELJANZ (tofacitinib) co-pay savings card

If you are unable to confirm your eligibility or have additional questions, call XELSOURCE at 1-844-935-5269.

For eligible underinsured or uninsured patients, XELSOURCE may offer financial assistance through the Pfizer Patient Assistance Program. Call XELSOURCE to learn more about these programs. Terms and conditions/eligibility requirements apply.

Sign Up Now